Reduced efficacy of multiple doses of CpG-matured dendritic cell tumor vaccine in an experimental model (original) (raw)

Profile image of Mohammad AghasadeghiMohammad Aghasadeghi

2011, Cellular Immunology

visibility

description

5 pages

link

1 file

Targeted Cancer Therapy by Dendritic Cell Vaccine

Minako Abe

Cancer Treatment - Conventional and Innovative Approaches, 2013

View PDFchevron_right

Optimization of Production of Anti-Cancer Vaccines Based on Dendritic Cells

Zélia Silva

2015

View PDFchevron_right

Immune responses regulation following antitumor dendritic cell-based prophylactic, concurrent, and therapeutic vaccination

Mohammad Aghasadeghi

Medical Oncology, 2011

View PDFchevron_right

Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines

Volker Witt

Journal of Cellular and Molecular Medicine, 2008

View PDFchevron_right

Dendritic cell-based vaccine in advanced melanoma

Emanuela Scarpi

Melanoma Research, 2011

View PDFchevron_right

Cancer Vaccines and Tumor Immunity

Veronica Preda

2007

View PDFchevron_right

Loading of dendritic cells for immunotherapy

A. Van Nuffel

ISBT Science Series, 2013

View PDFchevron_right

Transfected human dendritic cells to induce antitumor immunity

Hassan Rahimi

Gene Therapy, 1999

View PDFchevron_right

A Novel Dendritic Cell-Based Cancer Vaccine Produces Promising Results in a Syngenic CC-36 Murine Colon Adenocarcinoma Model

Marc Wallack

Journal of Surgical Research, 2007

View PDFchevron_right

NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity

Takuya Osada

Cancer Immunology, Immunotherapy, 2005

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells

Ji-li Chen

International Journal of Cancer, 2000

View PDFchevron_right

Tumor Antigen Processing and Presentation Depend Critically on Dendritic Cell Type and the Mode of Antigen Delivery

Ian Davis

…, 2005

View PDFchevron_right

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells

Jon Kyte

Cancer Immunology, Immunotherapy, 2006

View PDFchevron_right

In-situ tumor vaccination: Bringing the fight to the tumor

Robert Pierce

Human Vaccines & Immunotherapeutics, 2015

View PDFchevron_right

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

Allan Friedman

Nature, 2015

View PDFchevron_right

Human dendritic cell line models for DC differentiation and clinical DC vaccination studies

Tanja Gruijl

Journal of Leukocyte Biology, 2008

View PDFchevron_right

Therapeutic vaccines

James Gulley

Human Vaccines & Immunotherapeutics, 2013

View PDFchevron_right

Effective Dendritic Cell-based Immunotherapeutic Vaccines for Acute Myeloid Leukemia (AML)

Jamshid Hadjati

Vaccine Research, 2014

View PDFchevron_right

An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA–loaded dendritic cells for cancer vaccination

Elisabeth Brabants

Cytotherapy, 2018

View PDFchevron_right

Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress

Thomas Atwell

Journal for ImmunoTherapy of Cancer, 2014

View PDFchevron_right

Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model

Kimberly George

Cancer Immunology, Immunotherapy, 2003

View PDFchevron_right

Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy

Riccardo Dolcetti

OncoImmunology, 2017

View PDFchevron_right

Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells

William Mcbride

Cancer Gene Therapy, 1999

View PDFchevron_right

A Multipeptide Vaccine is Safe and Elicits T-cell Responses in Participants With Advanced Stage Ovarian Cancer

Craig Slingluff

Journal of Immunotherapy, 2008

View PDFchevron_right

Clinical application of dendritic cells in cancer vaccination therapy

Line soot

APMIS, 2003

View PDFchevron_right

Tumor's other immune targets: dendritic cells

Anna Lokshin, Watkins, Watkins, Galina Shurin

Journal of …, 1999

View PDFchevron_right

Potential role of dendritic cell vaccination with MAGE peptides in gastrointestinal carcinomas

Masaki Mori

Oncology Reports, 1994

View PDFchevron_right

Peptide Vaccines for Cancer Therapy

Grice Martínez

Recent Patents on Inflammation & Allergy Drug Discovery, 2015

View PDFchevron_right

Analysis of tumor-immune dynamics in a delayed dendritic cell therapy model

Yang Kuang

Chaos: An Interdisciplinary Journal of Nonlinear Science, 2020

View PDFchevron_right

Vaccine development: From concept to early clinical testing

Nathalie Garcon

Vaccine, 2016

View PDFchevron_right

Vaccines targeting the neovasculature of tumors

Archibald Mixson

Vascular Cell, 2011

View PDFchevron_right

Papillomavirus-Like Particles Induce Acute Activation of Dendritic Cells

Patricia Day

The Journal of Immunology, 2001

View PDFchevron_right

Clinical Evaluation of Dendritic Cells Vaccination for Advanced Cancer Patients at Fukushima Medical University

Atsushi Irisawa

FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2012

View PDFchevron_right

Dendritic cells in cancer vaccines

Peter Brossart

Experimental Hematology, 2001

View PDFchevron_right

Human Dendritic Cells: Potent Antigen-Presenting Cells at the Crossroads of Innate and Adaptive Immunity

marco rossi

The Journal of Immunology, 2005

View PDFchevron_right

ImmunologyMedicineDendritic CellsCellular ImmunologyCancer VaccinesCell therapyCell DifferentiationCellularMiceDendritic cellBase SequenceTumor GrowthExperimental Modeltumor immunity